Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LCTX

Lineage Cell Therapeutics, Inc.

CIK 0000876343 · NYSE American

NYSE AmericanHealth CareBiological Products, (No Diagnostic Substances)
$1.08
↑ 0.00 (0.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$273.14M
P/E Ratio
-8.47
EPS
-0.28
Dividend Yield
Not covered
52W Position
7%
Beta
1.41

Valuation multiples

Fwd P/E
30.67
PEG
10.64
P/B
4.57
P/S
20.88
EV/Revenue
18.02
ROE
-53.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 7%
$1.00$2.09

Latest Financials

2025-12-31 FY
Revenue
$14.56M
Net Income
-$63.53M
Total Assets
$112.58M
Free Cash Flow
-$19.44M

Recent news